Dynavax Technologies Corp (DVAX)
11.42
-0.34
(-2.89%)
USD |
NASDAQ |
Apr 24, 16:00
11.42
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Debt to Equity Ratio: 0.358 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.358 |
| September 30, 2023 | 0.3677 |
| June 30, 2023 | 0.3848 |
| March 31, 2023 | 0.3935 |
| December 31, 2022 | 0.3814 |
| September 30, 2022 | 0.4421 |
| June 30, 2022 | 0.5228 |
| March 31, 2022 | 0.7679 |
| December 31, 2021 | 0.9915 |
| September 30, 2021 | 3.259 |
| June 30, 2021 | 2.638 |
| March 31, 2021 | 1.803 |
| December 31, 2020 | 3.064 |
| September 30, 2020 | 2.594 |
| June 30, 2020 | 3.082 |
| March 31, 2020 | 15.19 |
| December 31, 2019 | 21.54 |
| September 30, 2019 | 4.536 |
| June 30, 2019 | 16.68 |
| March 31, 2019 | 4.070 |
| December 31, 2018 | 1.600 |
| September 30, 2018 | 1.034 |
| June 30, 2018 | 0.7598 |
| March 31, 2018 | 0.5982 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.1269 |
| March 31, 2015 | 0.1266 |
| December 31, 2014 | 0.0951 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.1111 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.1511 |
| December 31, 2011 | 0.1283 |
| September 30, 2011 | 0.3407 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.358
Minimum
Dec 2023
21.54
Maximum
Dec 2019
4.158
Average
1.803
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Supernus Pharmaceuticals Inc | 0.00 |
| Ligand Pharmaceuticals Inc | 0.00 |
| Pacira BioSciences Inc | 0.6004 |
| Esperion Therapeutics Inc | -0.5749 |
| PetIQ Inc | 2.018 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 997.10M |
| Total Liabilities (Quarterly) | 375.02M |
| Shareholders Equity (Quarterly) | 622.07M |
| Current Ratio | 13.81 |
| Net Debt Paydown Yield | -0.02% |